Skip to content
Search for:
The Society
Board of Directors
Scientific Advisory Council
Contact
Events Calendar
Mentor Program
Rare Disease Task Force
BOD Trainee Representatives
Awards & Grants
Local Delivery Grants
Lifetime Achievement Award
Young Investigator Award
Dr. Alan M. Gewirtz Memorial Scholarships
Award for Science Outreach or Patient Advocacy
Paper of the Year Awards
Travel Grants
Poster Awards
Science News
Recent Articles
President’s Pick and Perspective
Journal
Archive
Educational Video Library
Support for Ukrainian Scientists
Job Board
Employer Profiles
Employer Registration / Login
Events
Annual Meetings
2024 Annual Meeting
2023 Annual Meeting
Past Annual Meetings
2022 Annual Meeting
2022 Annual Meeting
Agenda
Abstracts & Awards
Exhibitors
Sponsors
Venue & Travel
2021 Annual Meeting
2020 Annual Meeting
Webinars
Events Calendar
Membership
Become A Member or Renew Membership
Featured Members
Search for:
Directed RNase H Cleavage of Nascent Transcripts Causes Transcription Termination.
OTS
Antisense/RNase H
,
Hot Papers
,
Long noncoding RNA
January 31, 2020
SHARE
Post Views:
525
Lai F, Damle SS, Ling KK, Rigo F.
Mol Cell. 2020 Jan 3. pii: S1097-2765(19)30959-1.
PubMed
Previous
Next
Related articles
miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease
miR-135a-5p mediates memory and synaptic impairments via the Rock2/Adducin1 signaling pathway in a mouse model of Alzheimer’s disease
April 23rd, 2021
Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates
Small extracellular vesicles containing miR-486-5p promote angiogenesis after myocardial infarction in mice and nonhuman primates
April 23rd, 2021
Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression
Decreased miR-214-3p activates NF-κB pathway and aggravates osteoarthritis progression
April 23rd, 2021
Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford progeria syndrome
Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson-Gilford progeria syndrome
April 23rd, 2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
April 23rd, 2021
Antisense oligonucleotide therapy in a humanized mouse model of MECP2 duplication syndrome
Antisense oligonucleotide therapy in a humanized mouse model of MECP2 duplication syndrome
April 23rd, 2021
Page load link
Go to Top